On Friday, Bluebird bio Inc (NASDAQ: BLUE) was 7.65% up from the session before settling in for the closing price of $3.79. A 52-week range for BLUE has been $3.56 – $28.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 160.48%. When this article was written, the company’s average yearly earnings per share was at 23.22%. With a float of $9.64 million, this company’s outstanding shares have now reached $9.73 million.
Let’s determine the extent of company efficiency that accounts for 248 employees. In terms of profitability, gross margin is -43.49%, operating margin of -596.15%, and the pretax margin is -565.89%.
Bluebird bio Inc (BLUE) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Bluebird bio Inc stocks. The insider ownership of Bluebird bio Inc is 1.08%, while institutional ownership is 31.00%. The most recent insider transaction that took place on Mar 03 ’25, was worth 2,289. In this transaction Chief Medical Officer of this company sold 584 shares at a rate of $3.92, taking the stock ownership to the 7,610 shares. Before that another transaction happened on Mar 03 ’25, when Company’s insider sold 500 for $3.92, making the entire transaction worth $1,960. This insider now owns 7,878 shares in total.
Bluebird bio Inc (BLUE) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 23.22% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 58.02% during the next five years compared to 38.66% growth over the previous five years of trading.
Bluebird bio Inc (NASDAQ: BLUE) Trading Performance Indicators
You can see what Bluebird bio Inc (BLUE) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.28. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -24.86, a number that is poised to hit -5.88 in the next quarter and is forecasted to reach -9.85 in one year’s time.
Technical Analysis of Bluebird bio Inc (BLUE)
Looking closely at Bluebird bio Inc (NASDAQ: BLUE), its last 5-days average volume was 0.59 million, which is a jump from its year-to-date volume of 0.36 million. As of the previous 9 days, the stock’s Stochastic %D was 39.91%. Additionally, its Average True Range was 0.34.
During the past 100 days, Bluebird bio Inc’s (BLUE) raw stochastic average was set at 4.39%, which indicates a significant decrease from 55.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 45.82% in the past 14 days, which was lower than the 190.49% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.55, while its 200-day Moving Average is $11.13. However, in the short run, Bluebird bio Inc’s stock first resistance to watch stands at $4.44. Second resistance stands at $4.79. The third major resistance level sits at $5.16. If the price goes on to break the first support level at $3.72, it is likely to go to the next support level at $3.35. Should the price break the second support level, the third support level stands at $3.00.
Bluebird bio Inc (NASDAQ: BLUE) Key Stats
There are 9,722K outstanding shares of the company, which has a market capitalization of 39.74 million. As of now, sales total 29,500 K while income totals -211,910 K. Its latest quarter income was 10,610 K while its last quarter net income were -60,810 K.
